Find Esomeprazole Magnesium manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Omeprazole magnesium, 161973-10-0, Prilosec otc, H 168/68 magnesium, 95382-33-5, Omeprazole (as magnesium)
Molecular Formula
C34H36MgN6O6S2
Molecular Weight
713.1  g/mol
InChI Key
KWORUUGOSLYAGD-UHFFFAOYSA-N
FDA UNII
426QFE7XLK

Esomeprazole Magnesium
The S-isomer of omeprazole.
1 2D Structure

Esomeprazole Magnesium

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
magnesium;5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide
2.1.2 InChI
InChI=1S/2C17H18N3O3S.Mg/c2*1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17;/h2*5-8H,9H2,1-4H3;/q2*-1;+2
2.1.3 InChI Key
KWORUUGOSLYAGD-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C([N-]2)C=CC(=C3)OC.CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C([N-]2)C=CC(=C3)OC.[Mg+2]
2.2 Other Identifiers
2.2.1 UNII
426QFE7XLK
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Esomeprazole

2. Esomeprazole Potassium

3. Esomeprazole Sodium

4. Esomeprazole Strontium

5. Esomeprazole Strontium Anhydrous

6. Nexium

7. Strontium, Esomeprazole

2.3.2 Depositor-Supplied Synonyms

1. Omeprazole Magnesium

2. 161973-10-0

3. Prilosec Otc

4. H 168/68 Magnesium

5. 95382-33-5

6. Omeprazole (as Magnesium)

7. 426qfe7xlk

8. Magnesium;5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide

9. Esomeprazole Magnesium Salt

10. Unii-426qfe7xlk

11. Omeprazole Magnesium [usan]

12. Omeprazole Magnesium [usan:usp]

13. Prilosec Otc (tn)

14. Esomeprazole(magnesium)

15. Omeprazole Magnesium Salt

16. Omeprazole Magnesium (usp)

17. Mls001165732

18. Schembl722792

19. Esomeprazole Magnesium (nexium)

20. Chembl1567328

21. Chebi:94401

22. H-168/68 Magnesium

23. Hms2878h13

24. Omeprazole Magnesium [vandf]

25. Mfcd06798050

26. Omeprazole Magnesium [mart.]

27. Omeprazole Magnesium [usp-rs]

28. Omeprazole Magnesium [who-dd]

29. Akos015896379

30. Akos025402081

31. Omeprazole Magnesium Salt [mi]

32. As-75082

33. Omeprazole Magnesium [orange Book]

34. Smr000550477

35. Omeprazole Magnesium [ep Monograph]

36. Omeprazole Magnesium [usp Impurity]

37. Omeprazole Magnesium [usp Monograph]

38. Ft-0657297

39. Sw220306-1

40. Talicia Component Omeprazole Magnesium

41. D05259

42. Omeprazole Magnesium Component Of Talicia

43. A810316

44. J-014249

45. Q-100195

46. Q27166253

47. 5-methoxy-1h-1,3-benzimidazol-2-yl (4-methoxy-3,5-dimethyl-2-pyridinyl)methyl Sulfoxide

48. (rs)-5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)-1h-benzimidazole, Magnesium Salt (2:1)

49. 5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)-1h-benzimidazole, Magnesium Salt

50. 5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)benzimidazole, Magnesium Salt (2:1)

51. Magnesium 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]benzimidazol-1-ide;esomeprazole Magnesium(random Configuration)

52. Magnesium(2+) 5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methanesulfinyl]-1h-1,3-benzodiazol-1-ide 6-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methanesulfinyl]-1h-1,3-benzodiazol-1-ide

53. Magnesium, Bis(6-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl-.kappa.o)-1h-benzimidazolato-.kappa.n3)-, (t-4)-

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 713.1 g/mol
Molecular Formula C34H36MgN6O6S2
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count14
Rotatable Bond Count10
Exact Mass712.1988169 g/mol
Monoisotopic Mass712.1988169 g/mol
Topological Polar Surface Area163 Ų
Heavy Atom Count49
Formal Charge0
Complexity453
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count2
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count3
4 Drug and Medication Information
4.1 Drug Information
1 of 6  
Drug NameEsomeprazole magnesium
PubMed HealthEsomeprazole
Drug ClassesGastric Acid Secretion Inhibitor, Gastrointestinal Agent
Drug LabelThe active ingredient in NEXIUM (esomeprazole magnesium) Delayed-Release Capsules and NEXIUM (esomeprazole magnesium) For Delayed-Release Oral Suspension is bis(5-methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole...
Active IngredientEsomeprazole magnesium
Dosage FormCapsule, delayed release
Routeoral
Strength40mg; 20mg
Market StatusTentative Approval
CompanyRanbaxy

2 of 6  
Drug NameNexium
Drug LabelThe active ingredient in NEXIUM (esomeprazole magnesium) Delayed-Release Capsules and NEXIUM (esomeprazole magnesium) For Delayed-Release Oral Suspension is bis(5-methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole...
Active IngredientEsomeprazole magnesium
Dosage FormCapsule, delayed rel pellets; For suspension, delayed release
RouteOral
Strengtheq 5mg base/packet; eq 20mg base/packet; eq 20mg base; eq 40mg base; eq 10mg base/packet; eq 40mg base/packet; eq 2.5mg base/packet
Market StatusPrescription
CompanyAstrazeneca

3 of 6  
Drug NameOmeprazole magnesium
Drug LabelThe active ingredient in NEXIUM (esomeprazole magnesium) Delayed-Release Capsules and NEXIUM (esomeprazole magnesium) For Delayed-Release Oral Suspension is bis(5-methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole...
Active IngredientOmeprazole magnesium
Dosage FormCapsule, delayed release
RouteOral
Strengtheq 20mg base
Market StatusOver the Counter
CompanyDr Reddys Labs

4 of 6  
Drug NameEsomeprazole magnesium
PubMed HealthEsomeprazole
Drug ClassesGastric Acid Secretion Inhibitor, Gastrointestinal Agent
Drug LabelThe active ingredient in NEXIUM (esomeprazole magnesium) Delayed-Release Capsules and NEXIUM (esomeprazole magnesium) For Delayed-Release Oral Suspension is bis(5-methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole...
Active IngredientEsomeprazole magnesium
Dosage FormCapsule, delayed release
Routeoral
Strength40mg; 20mg
Market StatusTentative Approval
CompanyRanbaxy

5 of 6  
Drug NameNexium
Drug LabelThe active ingredient in NEXIUM (esomeprazole magnesium) Delayed-Release Capsules and NEXIUM (esomeprazole magnesium) For Delayed-Release Oral Suspension is bis(5-methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole...
Active IngredientEsomeprazole magnesium
Dosage FormCapsule, delayed rel pellets; For suspension, delayed release
RouteOral
Strengtheq 5mg base/packet; eq 20mg base/packet; eq 20mg base; eq 40mg base; eq 10mg base/packet; eq 40mg base/packet; eq 2.5mg base/packet
Market StatusPrescription
CompanyAstrazeneca

6 of 6  
Drug NameOmeprazole magnesium
Drug LabelThe active ingredient in NEXIUM (esomeprazole magnesium) Delayed-Release Capsules and NEXIUM (esomeprazole magnesium) For Delayed-Release Oral Suspension is bis(5-methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole...
Active IngredientOmeprazole magnesium
Dosage FormCapsule, delayed release
RouteOral
Strengtheq 20mg base
Market StatusOver the Counter
CompanyDr Reddys Labs

5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Anti-Ulcer Agents

Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)


Proton Pump Inhibitors

Compounds that inhibit H(+)-K(+)-EXCHANGING ATPASE. They are used as ANTI-ULCER AGENTS and sometimes in place of HISTAMINE H2 ANTAGONISTS for GASTROESOPHAGEAL REFLUX. (See all compounds classified as Proton Pump Inhibitors.)


5.2 FDA Pharmacological Classification
5.2.1 Pharmacological Classes
Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]; Cytochrome P450 2C19 Inhibitors [MoA]

API SUPPLIERS

read-more
read-more
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-moreread-more

01

Minakem

France
arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMinakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

Flag France
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2019-11-25

Pay. Date : 2019-10-16

DMF Number : 34026

Submission : 2019-10-04

Status : Active

Type : II

Minakem Comapny Banner

02

Minakem

France
arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMinakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

Flag France
Digital Content Digital Content

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 28462

Submission : 2014-07-08

Status : Active

Type : II

Minakem Comapny Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGranules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Flag India
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2023-05-26

Pay. Date : 2023-04-18

DMF Number : 36556

Submission : 2021-12-24

Status : Active

Type : II

Granules India

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGranules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Flag India
Digital Content Digital Content

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 37233

Submission : 2022-07-01

Status : Active

Type : II

Granules India

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMetrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Flag India
Digital Content Digital Content

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 35519

Submission : 2020-12-29

Status : Active

Type : II

Metrochem

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMetrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Flag India
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2026-03-04

Pay. Date : 2026-02-06

DMF Number : 35400

Submission : 2020-11-28

Status : Active

Type : II

Metrochem

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2014-07-07

Pay. Date : 2014-04-21

DMF Number : 28127

Submission : 2014-03-31

Status : Active

Type : II

Dr Reddy Company Banner

08

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2013-11-18

Pay. Date : 2013-01-16

DMF Number : 25858

Submission : 2012-03-30

Status : Active

Type : II

Dr Reddy Company Banner

09

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2013-02-07

Pay. Date : 2013-01-16

DMF Number : 23994

Submission : 2010-07-26

Status : Active

Type : II

Dr Reddy Company Banner

10

BIO International Convention
Not Confirmed

10

Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

JDMF

read-more
read-moreread-more

01

BIO International Convention
Not Confirmed
arrow
arrow
BIO International Convention
Not Confirmed

Esomeprazole magnesium hydrate

Registration Number : 303MF10113

Registrant's Address : 4th Floor, OIA House, 470, Cardinal Gracious Road, Andheri East Mumbai 400099, Mahara...

Initial Date of Registration : 2021-07-16

Latest Date of Registration : 2021-07-16

blank

02

BIO International Convention
Not Confirmed
arrow
arrow
BIO International Convention
Not Confirmed

Esomeprazole magnesium hydrate

Registration Number : 303MF10137

Registrant's Address : Plot No. 2, Maitrivihar, Ameerpet, Hyderabad Telangana, India

Initial Date of Registration : 2021-08-20

Latest Date of Registration : 2021-08-20

blank

03

BIO International Convention
Not Confirmed
arrow
arrow
BIO International Convention
Not Confirmed

Esomeprazole magnesium hydrate "Apitoria"

Registration Number : 306MF10086

Registrant's Address : Plot No. 2, Maitrivihar, Ameerpet, Hyderabad, Telangana, INDIA.

Initial Date of Registration : 2024-07-03

Latest Date of Registration : 2024-07-03

blank

04

BIO International Convention
Not Confirmed
arrow
arrow
BIO International Convention
Not Confirmed

Esomeprazole magnesium hydrate

Registration Number : 303MF10107

Registrant's Address : No. 2066 Tangkou Road, Economy and Technology Development Zone, Hefei, Anhui Province...

Initial Date of Registration : 2021-07-09

Latest Date of Registration : 2025-06-18

blank

05

BIO International Convention
Not Confirmed
arrow
arrow
BIO International Convention
Not Confirmed

Esomeprazole magnesium hydrate

Registration Number : 303MF10115

Registrant's Address : No. 89 1st street, Lingbei Road, Lingchuan, Guilin Guangxi, PR China

Initial Date of Registration : 2021-07-20

Latest Date of Registration : 2021-07-20

blank

06

BIO International Convention
Not Confirmed
arrow
arrow
BIO International Convention
Not Confirmed

Esomeprazole magnesium hydrate "D"

Registration Number : 301MF10050

Registrant's Address : 7-2-A2, Hetero Corporate, Industrial Estates, Sanath Nagar, Hyderabad-500 018, Telang...

Initial Date of Registration : 2019-08-20

Latest Date of Registration : 2019-08-20

blank

07

BIO International Convention
Not Confirmed
arrow
arrow
BIO International Convention
Not Confirmed

Esomeprazole magnesium hydrate

Registration Number : 303MF10042

Registrant's Address : NORTH-EAST OF DONGWAIHUAN ROAD, DONGCHENG INDUSTRIAL AREA, SHOUGUANG CITY, SANDONG, C...

Initial Date of Registration : 2021-03-15

Latest Date of Registration : 2021-03-15

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more

Details:

Alemtuzumab is a Antibody drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Multiple Sclerosis, Relapsing-Remitting.


Lead Product(s): Alemtuzumab,Cetirizine,Ranitidine,Methylprednisolone,Acyclovir,Esomeprazole Magnesium,Ibuprofen,Paracetamol

Therapeutic Area: Neurology Brand Name: Undisclosed

Study Phase: Phase IVProduct Type: Antibody, Unconjugated

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable July 31, 2014

Sanofi Company Banner

01

Sanofi

France
arrow

Lead Product(s) : Alemtuzumab, Cetirizine, Ranitidine, Methylprednisolone, Acyclovir

Therapeutic Area : Neurology

Highest Development Status : Phase IV

Partner/Sponsor/Collaborator : Undisclosed

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Alemtuzumab is a Antibody drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Multiple Sclerosis, Relapsing-Remitting.

Product Name : Undisclosed

Product Type : Antibody, Unconjugated

Upfront Cash : Inapplicable

July 31, 2014

Sanofi Company Banner

Details:

The transaction includes Trustan, Altosec, Zuvamor, Ciavor, Grantryl and Aspen Granisetron brands. To secure uninterrupted patient access to these medicines, the parties have also signed a manufacturing and supply agreement.


Lead Product(s): Esomeprazole Magnesium,Inapplicable

Therapeutic Area: Gastroenterology Brand Name: Trustan

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Acino Pharma

Deal Size: $119.4 million Upfront Cash: Undisclosed

Deal Type: Acquisition October 22, 2021

Aspen API Comapny Banner

02

Details : The transaction includes Trustan, Altosec, Zuvamor, Ciavor, Grantryl and Aspen Granisetron brands. To secure uninterrupted patient access to these medicines, the parties have also signed a manufacturing and supply agreement.

Product Name : Trustan

Product Type : Miscellaneous

Upfront Cash : Undisclosed

October 22, 2021

Aspen API Comapny Banner

Details:

Esomeprazole magnesium hydrate capsules is a proton pump inhibitor indicated for the treatment of gastroesophageal reflux disease and NSAID-associated gastric ulcer.


Lead Product(s): Esomeprazole Magnesium,Inapplicable

Therapeutic Area: Gastroenterology Brand Name: Esomeprazole-Generic

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable February 14, 2024

Towa Pharmaceutical

03

Lead Product(s) : Esomeprazole Magnesium,Inapplicable

Therapeutic Area : Gastroenterology

Highest Development Status : Approved FDF

Partner/Sponsor/Collaborator : Undisclosed

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Esomeprazole magnesium hydrate capsules is a proton pump inhibitor indicated for the treatment of gastroesophageal reflux disease and NSAID-associated gastric ulcer.

Product Name : Esomeprazole-Generic

Product Type : Miscellaneous

Upfront Cash : Inapplicable

February 14, 2024

Towa Pharmaceutical

Details:

Esomeprazole magnesium delayed-release capsules is a proton pump inhibitor indicated for the treatment of gastroesophageal reflux disease and NSAID-associated gastric ulcer.


Lead Product(s): Esomeprazole Magnesium,Inapplicable

Therapeutic Area: Gastroenterology Brand Name: Nexium-Generic

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable October 19, 2023

Granules India

04

Lead Product(s) : Esomeprazole Magnesium,Inapplicable

Therapeutic Area : Gastroenterology

Highest Development Status : Approved FDF

Partner/Sponsor/Collaborator : Undisclosed

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Esomeprazole magnesium delayed-release capsules is a proton pump inhibitor indicated for the treatment of gastroesophageal reflux disease and NSAID-associated gastric ulcer.

Product Name : Nexium-Generic

Product Type : Miscellaneous

Upfront Cash : Inapplicable

October 19, 2023

Granules India

Details:

BAY2927088 is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Carcinoma, Non-Small-Cell Lung.


Lead Product(s): Sevabertinib,Esomeprazole Magnesium

Therapeutic Area: Oncology Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable April 22, 2024

Company Banner

05

Bayer AG

Germany
arrow

Lead Product(s) : Sevabertinib,Esomeprazole Magnesium

Therapeutic Area : Oncology

Highest Development Status : Phase I

Partner/Sponsor/Collaborator : Undisclosed

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : BAY2927088 is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Carcinoma, Non-Small-Cell Lung.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

April 22, 2024

Company Banner
  • Development Update

Details:

Linaprazan Glurate is a small molecule drug candidate, which is currently being evaluated in Phase I clinical studies.


Lead Product(s): Linaprazan Glurate,Amoxicillin Trihydrate,Clarithromycin,Bismuth Potassium Citrate,Esomeprazole Magnesium

Therapeutic Area: Undisclosed Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable December 19, 2025

blank

06

Jiangsu Sinorda Biomedicine

Country
arrow
BIO International Convention
Not Confirmed

Jiangsu Sinorda Biomedicine

Country
arrow
BIO International Convention
Not Confirmed

Details : Linaprazan Glurate is a small molecule drug candidate, which is currently being evaluated in Phase I clinical studies.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

December 19, 2025

blank

Details:

Naproxen, a small molecule product targeting Cyclooxygenase, shows promising results in treating Osteoarthritis.


Lead Product(s): Naproxen,Esomeprazole Magnesium

Therapeutic Area: Musculoskeletal Brand Name: Undisclosed

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable December 04, 2025

blank

07

BIO International Convention
Not Confirmed
BIO International Convention
Not Confirmed

Details : Naproxen, a small molecule product targeting Cyclooxygenase, shows promising results in treating Osteoarthritis.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

December 04, 2025

blank

Details:

INCB161734 is a drug candidate, which is currently being evaluated in Phase I clinical studies for the treatment of unspecified medical condition.


Lead Product(s): INCB161734,Itraconazole,Rifampicin,Esomeprazole Magnesium,Famotidine

Therapeutic Area: Undisclosed Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Undisclosed

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable June 12, 2025

blank

08

BIO International Convention
Not Confirmed
BIO International Convention
Not Confirmed

Details : INCB161734 is a drug candidate, which is currently being evaluated in Phase I clinical studies for the treatment of unspecified medical condition.

Product Name : Undisclosed

Product Type : Undisclosed

Upfront Cash : Inapplicable

June 12, 2025

blank

Details:

Nexium (Esomeprazole Magnesium) is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Esophagitis, Peptic.


Lead Product(s): Esomeprazole Magnesium,Inapplicable

Therapeutic Area: Gastroenterology Brand Name: Nexium

Study Phase: Phase IIIProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable February 27, 2025

blank

09

BIO International Convention
Not Confirmed
BIO International Convention
Not Confirmed

Details : Nexium (Esomeprazole Magnesium) is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Esophagitis, Peptic.

Product Name : Nexium

Product Type : Miscellaneous

Upfront Cash : Inapplicable

February 27, 2025

blank

Details:

Zasocitinib is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.


Lead Product(s): Zasocitinib,COC,Metformin,Digoxin,Esomeprazole Magnesium

Therapeutic Area: Undisclosed Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable January 27, 2025

blank

10

BIO International Convention
Not Confirmed
BIO International Convention
Not Confirmed

Details : Zasocitinib is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

January 27, 2025

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

INTERMEDIATE SUPPLIERS

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTagoor's product development expertise, backed by our comprehensive understanding of the processes, helps us offer high-quality APIs.

CAS Number : 86604-78-6

End Use API : Esomeprazole Magnesium

About The Company : Tagoor Laboratories, established in 2018 and part of the Tagoor Group, provides APIs, advanced intermediates, and key starting materials for critical and high-g...

Tagoor Laboratories

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTagoor's product development expertise, backed by our comprehensive understanding of the processes, helps us offer high-quality APIs.

CAS Number : 86604-75-3

End Use API : Esomeprazole Magnesium

About The Company : Tagoor Laboratories, established in 2018 and part of the Tagoor Group, provides APIs, advanced intermediates, and key starting materials for critical and high-g...

Tagoor Laboratories

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTagoor's product development expertise, backed by our comprehensive understanding of the processes, helps us offer high-quality APIs.

CAS Number : 73590-85-9

End Use API : Esomeprazole Magnesium

About The Company : Tagoor Laboratories, established in 2018 and part of the Tagoor Group, provides APIs, advanced intermediates, and key starting materials for critical and high-g...

Tagoor Laboratories

04

Dasami Lab

India
BIO International Convention
Not Confirmed
arrow

Dasami Lab

India
BIO International Convention
Not Confirmed
arrow

CAS Number : 73590-85-9

End Use API : Esomeprazole Magnesium

About The Company : Dasami Lab Private Limited incorporated with MCA on 24 July 2015. The Dasami Lab Private Limited is listed in the class of pvtltd company and classified as Non ...

blank

05

BIO International Convention
Not Confirmed
arrow
BIO International Convention
Not Confirmed
arrow

CAS Number : 86604-75-3

End Use API : Esomeprazole Magnesium

About The Company : Enal Drugs Private Limited,an ISO 9001 : 2000 certified company, specializes in developing and producing anti ulcerative drugs, their intermediates, other activ...

blank

06

BIO International Convention
Not Confirmed
arrow
BIO International Convention
Not Confirmed
arrow

CAS Number : 86604-75-3

End Use API : Esomeprazole Magnesium

About The Company : Enal Drugs Private Limited,an ISO 9001 : 2000 certified company, specializes in developing and producing anti ulcerative drugs, their intermediates, other activ...

blank

07

BIO International Convention
Not Confirmed
arrow
BIO International Convention
Not Confirmed
arrow

CAS Number : 73590-85-9

End Use API : Esomeprazole Magnesium

About The Company : Enal Drugs Private Limited,an ISO 9001 : 2000 certified company, specializes in developing and producing anti ulcerative drugs, their intermediates, other activ...

blank

08

BIO International Convention
Not Confirmed
arrow
BIO International Convention
Not Confirmed
arrow

CAS Number : 13811-71-7

End Use API : Esomeprazole Magnesium

About The Company : The Company was incorporated on 19.02.1993 to carry on the business of manufacturing of bulk drugs viz. Omeprazole,Ciprofloxacin, Dichloroflurobenzene, Naproxen...

blank

09

BIO International Convention
Not Confirmed
arrow
BIO International Convention
Not Confirmed
arrow

CAS Number : 87-91-2

End Use API : Esomeprazole Magnesium

About The Company : The Company was incorporated on 19.02.1993 to carry on the business of manufacturing of bulk drugs viz. Omeprazole,Ciprofloxacin, Dichloroflurobenzene, Naproxen...

blank

10

BIO International Convention
Not Confirmed
arrow
BIO International Convention
Not Confirmed
arrow

CAS Number : 161796-84-5

End Use API : Esomeprazole Magnesium

About The Company : TEXLAB INDUSTRIES was established in 1971, manufacturing & trading related business. TEXLAB INDUSTRIES - company launched by Late Shree AMBALAL MISTRY for local...

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - CAPSULE, DELAYED RELEASE;ORAL - EQ 2...DOSAGE - CAPSULE, DELAYED RELEASE;ORAL - EQ 20MG BASE

USFDA APPLICATION NUMBER - 204655

read-more

DOSAGE - CAPSULE, DELAYED REL PELLETS;ORAL - ...DOSAGE - CAPSULE, DELAYED REL PELLETS;ORAL - EQ 20MG BASE

USFDA APPLICATION NUMBER - 21153

read-more

DOSAGE - CAPSULE, DELAYED REL PELLETS;ORAL - ...DOSAGE - CAPSULE, DELAYED REL PELLETS;ORAL - EQ 40MG BASE

USFDA APPLICATION NUMBER - 21153

read-more

DOSAGE - FOR SUSPENSION, DELAYED RELEASE;ORAL...DOSAGE - FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 2.5MG BASE/PACKET

USFDA APPLICATION NUMBER - 21957

read-more

DOSAGE - FOR SUSPENSION, DELAYED RELEASE;ORAL...DOSAGE - FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 20MG BASE/PACKET

USFDA APPLICATION NUMBER - 21957

read-more

DOSAGE - FOR SUSPENSION, DELAYED RELEASE;ORAL...DOSAGE - FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 40MG BASE/PACKET

USFDA APPLICATION NUMBER - 21957

read-more

DOSAGE - FOR SUSPENSION, DELAYED RELEASE;ORAL...DOSAGE - FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 5MG BASE/PACKET

USFDA APPLICATION NUMBER - 21957

read-more

DOSAGE - TABLET, DELAYED RELEASE;ORAL - EQ 20...DOSAGE - TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;375MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 22511

read-more

DOSAGE - TABLET, DELAYED RELEASE;ORAL - EQ 20...DOSAGE - TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 22511

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Coating Systems & Additives

read-more
read-more

Fillers, Diluents & Binders

read-more
read-more

Controlled & Modified Release

read-more
read-more

Solubilizers

read-more
read-more

Direct Compression

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Taste Masking

read-more
read-more

Granulation

read-more
read-more

Lubricants & Glidants

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Topical

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Parenteral

read-more
read-more

Co-Processed Excipients

read-more
read-more

Emulsifying Agents

read-more
read-more

Empty Capsules

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

API Stability Enhancers

read-more
read-more

Vegetarian Capsules

read-more
read-more

Rheology Modifiers

read-more
read-more

Coloring Agents

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

WEEKLY NEWS RECAP #Phispers

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ANALYTICAL

Upload your methods for free, ask us

ABOUT THIS PAGE

Looking for 95382-33-5 / Esomeprazole Magnesium API manufacturers, exporters & distributors?

Esomeprazole Magnesium manufacturers, exporters & distributors 1

36

PharmaCompass offers a list of Esomeprazole Magnesium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Esomeprazole Magnesium manufacturer or Esomeprazole Magnesium supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Esomeprazole Magnesium manufacturer or Esomeprazole Magnesium supplier.

API | Excipient name

Esomeprazole Magnesium

Synonyms

Omeprazole magnesium, 161973-10-0, Prilosec otc, H 168/68 magnesium, 95382-33-5, Omeprazole (as magnesium)

Cas Number

95382-33-5

Unique Ingredient Identifier (UNII)

426QFE7XLK

About Esomeprazole Magnesium

The S-isomer of omeprazole.

Esomeprazole Manufacturers

A Esomeprazole manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Esomeprazole, including repackagers and relabelers. The FDA regulates Esomeprazole manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Esomeprazole API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Esomeprazole manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

Esomeprazole Suppliers

A Esomeprazole supplier is an individual or a company that provides Esomeprazole active pharmaceutical ingredient (API) or Esomeprazole finished formulations upon request. The Esomeprazole suppliers may include Esomeprazole API manufacturers, exporters, distributors and traders.

click here to find a list of Esomeprazole suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Esomeprazole USDMF

A Esomeprazole DMF (Drug Master File) is a document detailing the whole manufacturing process of Esomeprazole active pharmaceutical ingredient (API) in detail. Different forms of Esomeprazole DMFs exist exist since differing nations have different regulations, such as Esomeprazole USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Esomeprazole DMF submitted to regulatory agencies in the US is known as a USDMF. Esomeprazole USDMF includes data on Esomeprazole's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Esomeprazole USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Esomeprazole suppliers with USDMF on PharmaCompass.

Esomeprazole JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Esomeprazole Drug Master File in Japan (Esomeprazole JDMF) empowers Esomeprazole API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Esomeprazole JDMF during the approval evaluation for pharmaceutical products. At the time of Esomeprazole JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Esomeprazole suppliers with JDMF on PharmaCompass.

Esomeprazole KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Esomeprazole Drug Master File in Korea (Esomeprazole KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Esomeprazole. The MFDS reviews the Esomeprazole KDMF as part of the drug registration process and uses the information provided in the Esomeprazole KDMF to evaluate the safety and efficacy of the drug.

After submitting a Esomeprazole KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Esomeprazole API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Esomeprazole suppliers with KDMF on PharmaCompass.

Esomeprazole CEP

A Esomeprazole CEP of the European Pharmacopoeia monograph is often referred to as a Esomeprazole Certificate of Suitability (COS). The purpose of a Esomeprazole CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Esomeprazole EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Esomeprazole to their clients by showing that a Esomeprazole CEP has been issued for it. The manufacturer submits a Esomeprazole CEP (COS) as part of the market authorization procedure, and it takes on the role of a Esomeprazole CEP holder for the record. Additionally, the data presented in the Esomeprazole CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Esomeprazole DMF.

A Esomeprazole CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Esomeprazole CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Esomeprazole suppliers with CEP (COS) on PharmaCompass.

Esomeprazole WC

A Esomeprazole written confirmation (Esomeprazole WC) is an official document issued by a regulatory agency to a Esomeprazole manufacturer, verifying that the manufacturing facility of a Esomeprazole active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Esomeprazole APIs or Esomeprazole finished pharmaceutical products to another nation, regulatory agencies frequently require a Esomeprazole WC (written confirmation) as part of the regulatory process.

click here to find a list of Esomeprazole suppliers with Written Confirmation (WC) on PharmaCompass.

Esomeprazole NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Esomeprazole as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Esomeprazole API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Esomeprazole as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Esomeprazole and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Esomeprazole NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Esomeprazole suppliers with NDC on PharmaCompass.

Esomeprazole GMP

Esomeprazole Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Esomeprazole GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Esomeprazole GMP manufacturer or Esomeprazole GMP API supplier for your needs.

Esomeprazole CoA

A Esomeprazole CoA (Certificate of Analysis) is a formal document that attests to Esomeprazole's compliance with Esomeprazole specifications and serves as a tool for batch-level quality control.

Esomeprazole CoA mostly includes findings from lab analyses of a specific batch. For each Esomeprazole CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Esomeprazole may be tested according to a variety of international standards, such as European Pharmacopoeia (Esomeprazole EP), Esomeprazole JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Esomeprazole USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty